Bank of New Hampshire’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-497
Closed -$31.3K 466
2024
Q3
$31.3K Sell
497
-471
-49% -$27.5K 0.01% 325
2024
Q2
$57.2K Buy
968
+43
+5% +$2.69K 0.01% 306
2024
Q1
$73.8K Sell
925
-666
-42% -$50.9K 0.02% 279
2023
Q4
$126K Sell
1,591
-204
-11% -$14.5K 0.04% 235
2023
Q3
$125K Sell
1,795
-2,692
-60% -$191K 0.04% 224
2023
Q2
$310K Sell
4,487
-4,190
-48% -$298K 0.09% 157
2023
Q1
$645K Sell
8,677
-7,504
-46% -$629K 0.19% 113
2022
Q4
$1.51M Sell
16,181
-1,088
-6% -$105K 0.45% 63
2022
Q3
$1.65M Sell
17,269
-310
-2% -$30.7K 0.52% 56
2022
Q2
$1.63M Sell
17,579
-717
-4% -$70K 0.47% 59
2022
Q1
$1.85M Buy
18,296
+298
+2% +$31.3K 0.45% 60
2021
Q4
$1.86M Buy
17,998
+3,229
+22% +$298K 0.45% 66
2021
Q3
$1.23M Hold
14,769
0.33% 87
2021
Q2
$1.23M Buy
+14,769
New +$1.21M 0.33% 87

Other funds holding CVS

Bank of New Hampshire's CVS Position: Q4 2024 in Review

Bank of New Hampshire sold out of CVS Health (CVS) in Q4 2024, closing a stake of 497 shares — an estimated $31.3K sold.

Bank of New Hampshire first reported a position in CVS in Q2 2021 and held it in 14 quarters. The position peaked at $1.86M in Q4 2021. 1,670 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Bank of New Hampshire reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
  • Bank of New Hampshire sold 497 CVS Health shares in Q4 2024, an estimated $31.3K.
  • Bank of New Hampshire first reported a position in CVS Health in Q2 2021 and held it in 14 quarters.
  • Bank of New Hampshire's CVS Health position peaked at $1.86M in Q4 2021.
  • 1,670 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Bank of New Hampshire's 13F filing for Q4 2024, filed 7 Jan 2025.